Human Cancer

HCRC dedicates itself to various aspects such as prevention, early detection, diagnosis and precision medicine. HCRC conducts research on diagnostic, risk factors, and treatment at the level of tissue, cellular, molecular and proteomics. Thus, HCRC is expected to contribute to early, more accurate identification of cancer or to determine more precise therapy to support the quality of life of patients and the community.

Research Topic

  • Patient derived cancer models : spheroids/organoids in precision medicine.
  • Liquid biopsies : Investigating and exploring circulating tumor cells; exploring less invasive biomarkers detections.
  • Cancer genetics and biomarkers : gene fusion, expressions, and relations to clinical outcomes.
  • Cancer drug discovery.
  • Cancer screening and prevention strategies.

Ongoing Research Since 2022

  • Biomarker studies for diagnostic, prognostic or therapeutic outcome predictors.
  • Studies of genetic and epigenetic mutation profiles and their potential in identifying cancers due to hereditary factors.
  • Cervical Cancer Prevention and HPV Vaccination Promotion for adolescent girls.
  • Syndrome Profile Study with Microsatellite Instability (MSI)/ DNA Mismatch Repair (MMR) Examination in Young Colorectal Cancer Patients.
  • WNT Pathway Activation Study and Angiogenesis.

Recent Publications


  • Dr. Cipto Mangunkusumo National Central Public Hospital (RSUPN).
  • Female Cancer Programe, Leiden University.
  • Department of Biology, Faculty of Mathematics and Natural Sciences, University of Indonesia.
  • PT. PathGen Diagnostik Teknologi.
  • Nottingham-Indonesia Collaboration for Clinical Research and Training (NICCRAT).
  • Faculty of Medicine & Health Sciences, University of Nottingham.
  • Faculty of Medicine, Airlangga University.
  • CV. Abiramalab Indonesia.
  • All India Institute of Medical Sciences.
  • Graduate School of Pharmaceutical Sciences, Osaka University

Any Inquiries

  • Email :

Our Team